Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Pietro A. Canetta, MD

IgA nephropathy has a few aspects to it that make it challenging to develop medications, particularly, focused medications. So what are the challenges or limitations associated with the therapies? Join Dr. Charles Turck as he discusses this in-depth with Dr. Pietro Canetta, Associate Professor of Medicine at Columbia University Irving Medical Center.

Dr. Canetta did not receive compensation for this interview.